News Releases

Explore all the latest news from Johnson & Johnson Vision around the globe.*

Johnson & Johnson Vision Presents New Myopia, Cataract, Refractive, and Meibomian Gland Dysfunction Data at Virtual ARVO 2021 Annual Meeting
Johnson & Johnson Vision Presents New Myopia, Cataract, Refractive, and Meibomian Gland Dysfunction Data at Virtual ARVO 2021 Annual Meeting
Myopia progression data identifies key predictors of teenage High Myopia (HM), which may guide timing of early interventions to reduce risk of HM later in life Higher-order aspheric IOL shown to…
Johnson & Johnson Vision Presents New Myopia, Cataract, Refractive, and Meibomian Gland Dysfunction Data at Virtual ARVO 2021 Annual Meeting
Johnson & Johnson Vision Launches ACUVUE® 21 Day Challenge to Support Patients with Contact Lenses
Johnson & Johnson Vision Launches ACUVUE® 21 Day Challenge to Support Patients with Contact Lenses
New three-week programme designed to enhance the patient experience with contact lenses, from first fit to successful, ongoing use Resources available to eye care teams as practices expand their…
Johnson & Johnson Vision Launches ACUVUE® 21 Day Challenge to Support Patients with Contact Lenses
Johnson & Johnson Vision Receives Approval in Canada for World’s First and Only Drug-Releasing Contact Lens for Vision Correction and Allergic Eye Itch: ACUVUE® Theravision™ with Ketotifen
Johnson & Johnson Vision Receives Approval in Canada for World’s First and Only Drug-Releasing Contact Lens for Vision Correction and Allergic Eye Itch: ACUVUE® Theravision™ with Ketotifen

Health Canada approves ACUVUE® Theravision™ with Ketotifen, the first drug-releasing contact lens that provides vision correction to people experiencing itchy allergy eyes.  

…

Johnson & Johnson Vision Receives Approval in Canada for World’s First and Only Drug-Releasing Contact Lens for Vision Correction and Allergic Eye Itch: ACUVUE® Theravision™ with Ketotifen

Feature Stories

Johnson & Johnson Media Center

For more information about the latest Johnson & Johnson
news and publications visit the Media Center at www.jnj.com

Johnson & Johnson Media Center

Social Media LIVE

 

*Johnson & Johnson Vision medical device information contained in the News Releases are specific to the market highlighted and is not intended for dissemination outside the intended market.

PP2023OTH5448